Prosecution Insights
Prosecution Insights
5 pending office actions • 4 clients • 4 examiners • 3 art units • 0 of 5 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLDBERG, JEANINE ANNE | 2 | 45.9% | +40.8% |
| POLAND, CHERIE MICHELLE | 1 | 59.1% | +33.7% |
| BAUSCH, SARAE L | 1 | 29.6% | +44.2% |
| SISSON, BRADLEY L | 1 | 19.8% | +20.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17312248 | GENOMIC REARRANGEMENTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USING THE SAME | SISSON, BRADLEY L | 42d overdue |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18427083 | PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME | GOLDBERG, JEANINE ANNE | 86d overdue |
| 17312248 | GENOMIC REARRANGEMENTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USING THE SAME | SISSON, BRADLEY L | 42d overdue |
| 17627254 | AMPLIFICATION ASSAY FOR THE DETECTION OF ANAPLASMA PHAGOCYTOPHILUM | GOLDBERG, JEANINE ANNE | 23d overdue |
| 18857032 | LAYPERSON AUDIOVISUAL TOURNIQUET | POLAND, CHERIE MICHELLE | 5d overdue |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | BAUSCH, SARAE L | 15d |
| Client (Assignee) | Pending OAs |
|---|---|
| The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. | 2 |
| INNOVITAL, LLC | 1 |
| U.S. Government | 1 |
| Children's Medical Center | 1 |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| 3771 | 1 |
| 1699 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18857032 | LAYPERSON AUDIOVISUAL TOURNIQUET | Innovital, LLC | POLAND, CHERIE MICHELLE | 3771 | §103 | Non-Final OA | 5d overdue | Pending | Oct 15, 2024 |
| 18427083 | PROSTATE CANCER GENE PROFILES AND METHODS OF USING THE SAME | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 86d overdue | Pending | Jan 30, 2024 |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | BAUSCH, SARAE L | 1699 | §103 | Final Rejection | 15d | Pending | Sep 06, 2022 |
| 17627254 | AMPLIFICATION ASSAY FOR THE DETECTION OF ANAPLASMA PHAGOCYTOPHILUM | The United States Of America AS Represented By The Secretary Of The Navy | GOLDBERG, JEANINE ANNE | 1682 | §103 | Final Rejection | 23d overdue | Pending | Jan 14, 2022 |
| 17312248 | GENOMIC REARRANGEMENTS ASSOCIATED WITH PROSTATE CANCER AND METHODS OF USING THE SAME | Children'S Medical Center Corporation | SISSON, BRADLEY L | 1682 | §103 | Non-Final OA | 42d overdue | Pending | Jun 09, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial